These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28867335)

  • 21. A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.
    Eguchi K; Hoshide S; Komori T; Nagasaka S; Kario K
    Am J Hypertens; 2015 Aug; 28(8):971-9. PubMed ID: 25528450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlling evening BP as well as morning BP is important in hypertensive patients with prediabetes/diabetes: the JMS-1 study.
    Eguchi K; Matsui Y; Shibasaki S; Hoshide S; Kabutoya T; Ishikawa J; Ishikawa S; Shimada K; Kario K;
    Am J Hypertens; 2010 May; 23(5):522-7. PubMed ID: 20168303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Salles GF; Leite NC; Pereira BB; Nascimento EM; Cardoso CR
    J Hypertens; 2013 Nov; 31(11):2176-86. PubMed ID: 24029864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia G; O'Brien E; Palatini P; Tuomilehto J; Webster J;
    J Hypertens; 2004 Jan; 22(1):81-7. PubMed ID: 15106798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure.
    Karpettas N; Destounis A; Kollias A; Nasothimiou E; Moyssakis I; Stergiou GS
    Hypertens Res; 2014 Jun; 37(6):543-7. PubMed ID: 24572912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring blood pressure for decision making and quality reporting: where and how many measures?
    Powers BJ; Olsen MK; Smith VA; Woolson RF; Bosworth HB; Oddone EZ
    Ann Intern Med; 2011 Jun; 154(12):781-8, W-289-90. PubMed ID: 21690592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory blood pressure and abnormal albuminuria in type 1 diabetic patients.
    Hansen KW; Poulsen PL; Mogensen CE
    Kidney Int Suppl; 1994 Feb; 45():S134-40. PubMed ID: 8158882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes.
    Noguchi Y; Asayama K; Staessen JA; Inaba M; Ohkubo T; Hosaka M; Satoh M; Kamide K; Awata T; Katayama S; Imai Y;
    J Hypertens; 2013 Aug; 31(8):1593-602. PubMed ID: 23673350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of masked hypertension in treated hypertensive patients with type 2 diabetes mellitus.
    Alsuwaida A; Parkes R; So J; Feig D; Logan A
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):326-37. PubMed ID: 16970252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study.
    Stergiou GS; Alamara C; Drakatos A; Stefanidis CJ; Vazeou A
    Hypertens Res; 2009 Aug; 32(8):680-4. PubMed ID: 19498440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.